Abstract P3-05-18: Prognostic value of ctDNA dynamics and protein biomarkers in patients treated with alpelisib (ALP) and endocrine therapy (ET) for HR+/HER2- PIK3CA-mutated advanced breast cancer (ABC) in all 3 cohorts of the phase II BYLieve study
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Dejan Juric, Yoon-Sim Yap, Stephen Chia, Sherene Loi, Fabrice André, Nicholas Turner, Patrick Neven, Eva M. Ciruelos, Sara M. Tolaney, Jessica Makofske, Mukta Joshi, Estelle Roux, Murat Akdere, Hope S. Rugo
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411284580